NDC11 59148040075
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 59148-0400-75 | 59148-0400 |
| 59148-400-75 | 59148-400 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VOYXACT | SIBEPRENLIMAB | Otsuka America Pharmaceutical, Inc. | c8a93b32-0676-4704-86dc-cb65f425c6e5 | 2026-03-17 | Warnings, Adverse reactions | 59148-400-75 59148-400 59148040075 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.